Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study

Inclusion Criteria: Phases 1 \& 2: * Breast cancer survivors * Hx of early-stage breast cancer (DCIS and Stages I, II and III)as recorded in the medical record at MSK or by self-report or by outside correspondence, including a study checklist signed by a physician for patients outside of MSK. * ≥ 3 months post completion of breast cancer treatment (may be on hormone therapy, such as tamoxifen) with no history of recurrence or metastasis as confirmed by the medical record at MSK, self- report or by outside correspondence * Age 18 or older * Able to read and speak English * An overall fear index score of ≥ 3.0 on the CARS * If taking medication for mood, anxiety, depression, thoughts, sensory experiences such as hallucinations, or sleep, stable and consistent enough in dosage and use of that medication so as to not result in a clinically significant change as determined by the study PI/co-PI or confirmed by reports in the medical record at MSK or by self-report or by outside correspondence, including a study checklist signed by a physician for patients outside of MSK * If in non-CBT psychotherapy, stable for at least 8 weeks * Access to a computer or willingness to come to MSK to complete intervention sessions 2-8 and the 3-month follow-up assessment, if no personal computer. * For Part 2 only, did not participate in Part 1 Phase 3, Part 1 and 2: * Hx of early-stage breast cancer (DCIS and Stages I, II, and III) as recorded in the medical record at MSK or by self-report or …